肺癌内科的治疗进展.pptxVIP

非小细胞肺癌内科治疗进展;化疗进展;辅助治疗的必要性;辅助化疗;BRCA1水平和含铂药物化疗的相关性;Customized BRCA1 Adjuvant Treatment in Stage II-II NSCLC (SCAT);Presented By Mark Socinski at 2015 ASCO Annual Meeting;实验组的OS;Massuti B, et al. 2015 ASCO Abstract 7507.;Massuti B, et al. 2015 ASCO Abstract 7507.;分子学分析指导下的晚期NSCLC患者全球III期研究：研究设计;研究结果：PFS和OS;So what can we conclude from this study and what are the issues?;化疗进展;Unresectable Stage III NSCLC; ;不可手术的III期NSCLC;Is CisPem “worthy” of a Phase III Trial in stage III NSCLC?;PROCLAIM: Study Design;Presented By Mark Socinski at 2015 ASCO Annual Meeting;PROCLAIM: Primary Endpoint, OS;PROCLAI